Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events

CONNOLLY S;YUSUF S;BUDAJ A;CAMM J;CHROLAVICIUS S;COMMERFORD P. J;FLATHER M;FOX K. A;HART R;HOHNLOSER S;JOYNER C;PFEFFER M;ANAND I;ARTHUR H;AVEZUM A;BETHALA SITHYA M;BLUMENTHAL M;CEREMUZYNSKI L;DE CATERINA, Raffaele;DIAZ R;FLAKER G;FRANGIN G;FRANZOSI M. G;GAUDIN C;GOLITSYN S;GOLDHABER S;GRANGER C;HALON D;HERMOSILLO A;HUNT D;JANSKY P;KARATZAS N;KELTAI M;LANAS F;LAU C. P;LE HEUZEY J. Y;LEWIS B. S;MORAIS J;MORILLO C;OTO A;PAOLASSO E;PETERS R. J;PFISTERER M;PIEGAS L;PIPILLIS T;PROSTE C;SITKEI E;SWEDBERG K;SYNHORST D;TALAJIC M;TREGOU V;VALENTIN V;VAN MIEGHEM W;WEINTRAUB W;VARIGOS J.

2006-01-01